State Administration of Traditional Chinese Medicine

State Administration of Traditional Chinese Medicine
Name	State Administration of Traditional Chinese Medicine
Native name	国家中医药管理局
Formation	1998
Dissolved	2018
Superseding	National Administration of Traditional Chinese Medicine (restructured)
Headquarters	Beijing
Jurisdiction	People's Republic of China
Chief1 name	(various)
Parent department	State Council

State Administration of Traditional Chinese Medicine The State Administration of Traditional Chinese Medicine was a ministerial-level agency of the State Council (China) responsible for oversight of Traditional Chinese medicine policies, institutions, and standards from its formation in 1998 until organizational reforms. It coordinated with provincial and municipal bodies such as the Beijing Municipal Commission of Health and Family Planning and national bodies including the National Health Commission and the Ministry of Finance (China), engaging hospitals, universities, research institutes, and pharmaceutical enterprises across the People's Republic of China. Its remit intersected with prominent institutions like Beijing University of Chinese Medicine, Nanjing University of Chinese Medicine, and international organizations such as the World Health Organization.

History

Established in 1998 during administrative reforms that followed directives from the Central Committee of the Chinese Communist Party and the State Council (China), the agency emerged amid debates involving stakeholders like Zhongguancun research centers and provincial administrations including Guangdong Provincial Government and Sichuan Provincial Government. Its evolution was influenced by historical figures and texts tied to Hua Tuo, Li Shizhen, and the medical canon exemplified by the Huangdi Neijing. The administration navigated policy shifts under leaders from the Jiang Zemin and Hu Jintao periods, and reorganizations during the Xi Jinping era culminated in its functions being incorporated into a restructured national apparatus alongside entities such as the National Health Commission and the Chinese Academy of Sciences. Notable events included coordination during public health incidents like the SARS outbreak and contributions to national strategies reflected in plans promulgated by the National People's Congress.

Organization and Structure

The agency operated within the bureaucratic framework of the State Council (China), with a headquarters in Beijing and liaison offices interacting with provincial bureaus in Guangdong, Jiangsu, Zhejiang, Sichuan, and Shandong. Internal divisions paralleled departments in the Ministry of Education (China), National Development and Reform Commission, and the Ministry of Commerce (China), encompassing departments for clinical regulation, pharmaceutical oversight, education, and international cooperation. It had formal links to academic institutions such as Beijing University of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, and research bodies like the Chinese Academy of Medical Sciences and provincial key laboratories. The leadership included appointments approved by the State Council, working with advisory committees drawn from hospitals like Guangdong Provincial Hospital of Traditional Chinese Medicine and professional associations such as the China Association of Chinese Medicine.

Functions and Responsibilities

Mandated functions included registering and accrediting practitioners and institutions in coordination with municipal health commissions and educational authorities like the Ministry of Education (China), formulating standards for herbal medicines via cooperation with the Chinese Pharmacopoeia Commission and regulatory agencies such as the National Medical Products Administration, and guiding clinical pathways employed in hospitals including Xiyuan Hospital and Changhai Hospital. The agency promoted integration of TCM into public health systems, collaborating with bodies like the National Health Commission on campaigns and emergency responses linked to events like the 2008 Sichuan earthquake. It supervised licensure frameworks, oversight of pharmaceutical enterprises including listed firms on the Shanghai Stock Exchange and Shenzhen Stock Exchange, and promulgated practitioner curricula in partnership with universities such as Nanjing University of Chinese Medicine.

Policies and Regulations

The agency issued administrative measures and technical guidelines aligned with national policies formulated by the State Council (China) and enacted through ministries including the Ministry of Finance (China) and the Ministry of Human Resources and Social Security. Policies addressed formulation of the Chinese Pharmacopoeia, standards for raw materials from regions like Yunnan and Hubei, and quality control of products from manufacturers regulated by the National Medical Products Administration. Regulatory activity interfaced with laws passed by the National People's Congress and directives from the Central Committee of the Chinese Communist Party, including standards for hospital accreditation adopted by institutions such as Peking Union Medical College Hospital when integrating TCM services.

Research, Education, and Standards

The administration funded research networks linking the Chinese Academy of Sciences, Chinese Academy of Engineering, and universities including Beijing University of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, and Tianjin University of Traditional Chinese Medicine. It set curricular standards for degree programs coordinated with the Ministry of Education (China) and professional examinations administered with provincial education bureaus. Collaborative projects involved institutes such as the China Academy of Chinese Medical Sciences and hospitals like Hunan Provincial Hospital of Traditional Chinese Medicine, fostering clinical trials, standardization of herbal materia medica sourced from provinces like Shaanxi and Gansu, and development of pharmacopeial monographs in the Chinese Pharmacopoeia Commission framework. Research partnerships extended to bodies including the World Health Organization and foreign universities in Australia, United Kingdom, and United States.

International Cooperation and Exchanges

The agency coordinated cultural and scientific exchanges with foreign counterparts such as the World Health Organization, the United Nations Educational, Scientific and Cultural Organization, and bilateral health agencies in countries like Russia, Germany, France, Japan, South Korea, and India. It organized delegations to institutions including Harvard Medical School, University of Oxford, and Karolinska Institute, and hosted international conferences with participation from bodies like the World Federation of Chinese Medicine Societies and the International Society for Complementary Medicine Research. Programs included training collaborations with hospitals in Singapore and joint research endeavors with universities such as Johns Hopkins University and University of California, San Francisco.

Criticism and Controversies

The agency faced critiques from international and domestic actors including academics at Peking University and commentators in outlets covering public health policy, concerning evidence standards compared to protocols in institutions like the Cochrane Collaboration and regulatory approaches exemplified by the European Medicines Agency and the United States Food and Drug Administration. Controversies involved debates over clinical trial rigor at institutions such as Nanjing University of Chinese Medicine, claims regarding efficacy juxtaposed with research norms at the Chinese Academy of Medical Sciences, sourcing of herbal ingredients from regions like Yunnan and Inner Mongolia, and intellectual property disputes with universities including Tsinghua University and firms listed on the Shanghai Stock Exchange. Policy tensions emerged during administrative restructuring under leadership of the State Council (China) and in response to public health events such as the SARS outbreak, provoking discussion among scholars at Fudan University, Zhejiang University, and Sun Yat-sen University.

Category:Health organizations of China